Congressional Research Service Reports - Browse

ABOUT BROWSE FEED

Medicare: Prescription Drug Proposals

Description: This report provides an overview of the President’s plan and the legislation introduced to date in the 106th Congress. It
Date: June 8, 2000
Creator: O'Sullivan, Jennifer
Item Type: Report
Partner: UNT Libraries Government Documents Department

Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation

Description: This report provides an analysis of how the cost-sharing and premium provisions under the Prescription Drug and Medicare Improvement Act of 2003 (S. 1) and the Medicare Prescription Drug and Modernization Act of 2003 (H bill would affect the amount that a beneficiary would pay annually for prescription drugs.
Date: July 25, 2003
Creator: Peterson, Chris L
Item Type: Report
Partner: UNT Libraries Government Documents Department

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Description: This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
Date: June 17, 2003
Creator: Peterson, Chris L
Item Type: Report
Partner: UNT Libraries Government Documents Department

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Description: This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
Date: June 26, 2003
Creator: Peterson, Chris L
Item Type: Report
Partner: UNT Libraries Government Documents Department

Medicare Prescription Drug and Reform Legislation

Description: This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
Date: June 19, 2003
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L; Boulanger, Jennifer & Morgan, Paulette C
Item Type: Report
Partner: UNT Libraries Government Documents Department

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress.
Date: June 19, 2000
Creator: Schacht, Wendy H.
Item Type: Report
Partner: UNT Libraries Government Documents Department